Citation Impact
Citing Papers
Combined MYC Activation and Pten Loss Are Sufficient to Create Genomic Instability and Lethal Metastatic Prostate Cancer
2015
Multiphoton Phosphorescence Quenching Microscopy Reveals Kinetics of Tumor Oxygenation during Antiangiogenesis and Angiotensin Signaling Inhibition
2022 StandoutNobel
Development of a Second-Generation Antiandrogen for Treatment of Advanced Prostate Cancer
2009 StandoutScience
Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet
2009 Standout
The Prioritization of Cancer Antigens: A National Cancer Institute Pilot Project for the Acceleration of Translational Research
2009 StandoutNobel
High-Throughput Cell-Based Screening of 4910 Known Drugs and Drug-like Small Molecules Identifies Disulfiram as an Inhibitor of Prostate Cancer Cell Growth
2009
lincRNAs: Genomics, Evolution, and Mechanisms
2013 Standout
Mechanisms of SARS-CoV-2 entry into cells
2021 Standout
Phosphorylation of ETS1 by Src Family Kinases Prevents Its Recognition by the COP1 Tumor Suppressor
2014 StandoutNobel
ETS gene fusions in prostate cancer
2009
Angiotensin II Facilitates Breast Cancer Cell Migration and Metastasis
2012
MYC on the Path to Cancer
2012 Standout
A view on drug resistance in cancer
2019 StandoutNature
The renin–angiotensin system and cancer: old dog, new tricks
2010
A C. elegans genome-scale microRNA network contains composite feedback motifs with high flux capacity
2008 StandoutNobel
Cancer nanomedicine: progress, challenges and opportunities
2016 Standout
Multistage Nanoparticles for Improved Delivery into Tumor Tissue
2012 StandoutNobel
Increased Survival with Enzalutamide in Prostate Cancer after Chemotherapy
2012 Standout
Complex patterns of ETS gene alteration arise during cancer development in the human prostate
2007
Cancer nanotechnology: The impact of passive and active targeting in the era of modern cancer biology
2013 Standout
Convergence of Mutation and Epigenetic Alterations Identifies Common Genes in Cancer That Predict for Poor Prognosis
2008
Cellular senescence in aging and age-related disease: from mechanisms to therapy
2015 Standout
Principles of nanoparticle design for overcoming biological barriers to drug delivery
2015 Standout
The emerging role of lncRNAs in cancer
2015 Standout
Translating cancer research into targeted therapeutics
2010 Nature
Long Noncoding RNAs in Cancer Pathways
2016 Standout
Genome-wide analyses reveal properties of redundant and specific promoter occupancy within the ETS gene family
2007
Reduced Risk of Breast Cancer Recurrence in Patients Using ACE Inhibitors, ARBs, and/or Statins
2011
Analysis of Circulating Tumor DNA to Monitor Metastatic Breast Cancer
2013 Standout
Alterations in Nucleolar Structure and Gene Expression Programs in Prostatic Neoplasia Are Driven by the MYC Oncogene
2011
The Human Transcription Factors
2018 Standout
Origin of Chromosomal Translocations in Lymphoid Cancer
2010
The ETS family of oncogenic transcription factors in solid tumours
2017
ETV1 is a lineage survival factor that cooperates with KIT in gastrointestinal stromal tumours
2010 Nature
Genome-wide analysis of ETS-family DNA-binding in vitro and in vivo
2010
Tumor-associated copy number changes in the circulation of patients with prostate cancer identified through whole-genome sequencing
2013
Polycomb group proteins: navigators of lineage pathways led astray in cancer
2009
Triggers for genomic rearrangements: insights into genomic, cellular and environmental influences
2010
The landscape of long noncoding RNAs in the human transcriptome
2015 Standout
Antibody therapy of cancer
2012 Standout
Inflammation and Colon Cancer
2010 Standout
Spotlight on the role of COP1 in tumorigenesis
2012
The DNA Damage Response: Making It Safe to Play with Knives
2010 Standout
Transcript assembly and quantification by RNA-Seq reveals unannotated transcripts and isoform switching during cell differentiation
2010 Standout
Drug repurposing: progress, challenges and recommendations
2018 Standout
Molecular Mechanisms of Long Noncoding RNAs
2011 Standout
Chromosomal Abnormalities in Cancer
2008
Fluorescent Nanorods and Nanospheres for Real‐Time In Vivo Probing of Nanoparticle Shape‐Dependent Tumor Penetration
2011 StandoutNobel
Some active areas of DC research and their medical potential
2010 StandoutNobel
Liquid biopsies come of age: towards implementation of circulating tumour DNA
2017 Standout
RNA biomarkers associated with metastatic progression in prostate cancer: a multi-institutional high-throughput analysis of SChLAP1
2014
Genome editing with CRISPR–Cas nucleases, base editors, transposases and prime editors
2020 Standout
Type II transmembrane serine proteases in development and disease
2007
An ultrasensitive method for quantitating circulating tumor DNA with broad patient coverage
2014 Standout
Angiotensin inhibition enhances drug delivery and potentiates chemotherapy by decompressing tumour blood vessels
2013 StandoutNobel
Doxil® — The first FDA-approved nano-drug: Lessons learned
2012 Standout
Recurrent gene fusions in prostate cancer
2008
Use of cancer‐specific genomic rearrangements to quantify disease burden in plasma from patients with solid tumors
2010
Repertoire Enhancement with Adoptively Transferred Female Lymphocytes Controls the Growth of Pre-Implanted Murine Prostate Cancer
2012 StandoutNobel
Insights into the regulation of protein abundance from proteomic and transcriptomic analyses
2012 Standout
Homozygous Deletions and Recurrent Amplifications Implicate New Genes Involved in Prostate Cancer
2008
Clonal evolution in cancer
2012 StandoutNature
The functions and regulation of the PTEN tumour suppressor
2012 Standout
Chromosomal translocations in cancer
2008
Transcriptome sequencing across a prostate cancer cohort identifies PCAT-1, an unannotated lincRNA implicated in disease progression
2011
Imatinib potentiates antitumor T cell responses in gastrointestinal stromal tumor through the inhibition of Ido
2011 StandoutNobel
A decade of exploring the cancer epigenome — biological and translational implications
2011 Standout
Aberrant ERG expression cooperates with loss of PTEN to promote cancer progression in the prostate
2009
Evaluation of tissue PCA3 expression in prostate cancer by RNA in situ hybridization—a correlative study with urine PCA3 and TMPRSS2-ERG
2013
Next-generation transcriptome assembly
2011
How does DNA break during chromosomal translocations?
2011
COP1 is a tumour suppressor that causes degradation of ETS transcription factors
2011 Nature
Gene regulation by long non-coding RNAs and its biological functions
2020 Standout
Transcriptome sequencing to detect gene fusions in cancer
2009 Nature
Abiraterone plus Prednisone in Metastatic, Castration-Sensitive Prostate Cancer
2017 Standout
Genomic and Epigenetic Instability in Colorectal Cancer Pathogenesis
2008
The Emergence of lncRNAs in Cancer Biology
2011
Genome Regulation by Long Noncoding RNAs
2012 Standout
Making a virtue of necessity: the pleiotropic role of human endogenous retroviruses in cancer
2017
Exosomes
2019 Standout
Long Noncoding RNA and Cancer: A New Paradigm
2017 Standout
New Strategies in Metastatic Prostate Cancer: Targeting the Androgen Receptor Signaling Pathway
2011
Cancer Immunoediting: Integrating Immunity’s Roles in Cancer Suppression and Promotion
2011 StandoutScience
KLK3, PCA3, and TMPRSS2-ERG expression in the peripheral blood mononuclear cell fraction from castration-resistant prostate cancer patients and response to docetaxel treatment
2014
Differential p53-Independent Outcomes of p19 Arf Loss in Oncogenesis
2009
A New Initiative on Precision Medicine
2015 Standout
Antisense transcription at the TRPM2 locus as a novel prognostic marker and therapeutic target in prostate cancer
2014
Liquid Biopsies: Genotyping Circulating Tumor DNA
2014 Standout
Overcoming Persistent Dependency on Androgen Signaling after Progression to Castration-Resistant Prostate Cancer
2010
Evolutionary Comparison of the Mechanism of DNA Cleavage with Respect to Immune Diversity and Genomic Instability
2012 StandoutNobel
Losartan inhibits collagen I synthesis and improves the distribution and efficacy of nanotherapeutics in tumors
2011
Exome sequencing identifies a spectrum of mutation frequencies in advanced and lethal prostate cancers
2011
Works of Beth E. Helgeson being referenced
Characterization of TMPRSS2:ETV5 and SLC45A3:ETV5 Gene Fusions in Prostate Cancer
2008
Noninvasive Detection of TMPRSS2:ERG Fusion Transcripts in the Urine of Men with Prostate Cancer
2006
AGTR1 overexpression defines a subset of breast cancer and confers sensitivity to losartan, an AGTR1 antagonist
2009
Role of the TMPRSS2-ERG Gene Fusion in Prostate Cancer
2008
Distinct classes of chromosomal rearrangements create oncogenic ETS gene fusions in prostate cancer
2007 Nature
TMPRSS2:ETV4 Gene Fusions Define a Third Molecular Subtype of Prostate Cancer
2006